Histone variants and their post-translational modifications in primary human fat cells.
Epigenetic changes related to human disease cannot be fully addressed by studies of cells from cultures or from other mammals. We isolated human fat cells from subcutaneous abdominal fat tissue of female subjects and extracted histones from either purified nuclei or intact cells. Direct acid extraction of whole adipocytes was more efficient, yielding about 100 µg of protein with histone content of 60%-70% from 10 mL of fat cells. Differential proteolysis of the protein extracts by trypsin or ArgC-protease followed by nanoLC/MS/MS with alternating CID/ETD peptide sequencing identified 19 histone variants. Four variants were found at the protein level for the first time; particularly HIST2H4B was identified besides the only H4 isoform earlier known to be expressed in humans. Three of the found H2A potentially organize small nucleosomes in transcriptionally active chromatin, while two H2AFY variants inactivate X chromosome in female cells. HIST1H2BA and three of the identified H1 variants had earlier been described only as oocyte or testis specific histones. H2AFX and H2AFY revealed differential and variable N-terminal processing. Out of 78 histone modifications by acetylation/trimethylation, methylation, dimethylation, phosphorylation and ubiquitination, identified from six subjects, 68 were found for the first time. Only 23 of these modifications were detected in two or more subjects, while all the others were individual specific. The direct acid extraction of adipocytes allows for personal epigenetic analyses of human fat tissue, for profiling of histone modifications related to obesity, diabetes and metabolic syndrome, as well as for selection of individual medical treatments.
Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Asa
A
Jufvas
Peter
P
Strålfors
Alexander V
AV
Vener
D017667:Adipocytes / Q000737:chemistry / Q000166:cytology*; D017398:Alternative Splicing; D002469:Cell Separation / Q000379:methods; D002478:Cells, Cultured; D057890:Epigenomics; D005260:Female; D006657:Histones / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D011499:Protein Processing, Post-Translational / Q000235:genetics; D053719:Tandem Mass Spectrometry; D049951:X Chromosome Inactivation
C468783:H2AX protein, human; D006657:Histones
Science. 2001 Aug 10;293(5532):1074-80
11498575
Mol Med. 2010 Jul-Aug;16(7-8):235-46
20386866
Cell Cycle. 2010 Jul 1;9(13):2568-74
20543561
PLoS One. 2009;4(2):e4479
19229332
Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):60-5
17190813
Genomics. 2002 Nov;80(5):487-98
12408966
J Biol Chem. 1998 Mar 6;273(10):5858-68
9488723
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2808-13
15710904
EMBO J. 2010 Apr 21;29(8):1446-57
20360682
J Proteome Res. 2009 Sep;8(9):4207-15
19552482
Expert Rev Proteomics. 2007 Aug;4(4):491-503
17705707
Carcinogenesis. 1988 Mar;9(3):419-25
3125994
Mol Biotechnol. 2002 Jan;20(1):107-18
11876295
J Biol Chem. 1994 Feb 11;269(6):4144-51
8307975
Nat Genet. 2004 Jan;36(1):40-5
14702039
Biochemistry. 2009 Nov 24;48(46):10852-7
19856965
J Biol Chem. 2002 Nov 8;277(45):43474-80
12213818
Mol Cell Proteomics. 2009 Oct;8(10):2266-84
19654425
Diabetes. 2009 May;58(5):1229-36
19208907
Development. 2001 Mar;128(5):655-64
11171391
J Am Soc Mass Spectrom. 2009 Sep;20(9):1652-9
19523847
Genes Dev. 2009 Jul 1;23(13):1522-33
19515975
J Exp Med. 2008 Sep 29;205(10):2409-17
18809715
Anal Chem. 2008 Jul 1;80(13):4825-35
18540640
J Biol Chem. 2000 Apr 28;275(17):13007-11
10777603
Diabetes. 2000 Dec;49(12):2208-11
11118027
Mol Cell Proteomics. 2007 Jan;6(1):72-87
17043054
J Proteome Res. 2008 Oct;7(10):4225-36
18700791
J Nutr. 2010 Mar;140(3):662-6
20107142
Curr Opin Genet Dev. 2002 Apr;12(2):162-9
11893489
J Biol Chem. 1997 Oct 24;272(43):27476-83
9341202
Science. 2009 Aug 14;325(5942):834-40
19608861
Mol Cell Biochem. 2005 Nov;279(1-2):133-9
16283522
Nat Struct Mol Biol. 2007 Nov;14(11):1017-24
17984964
Diabetologia. 2007 May;50(5):1099-108
17370059
Nature. 2009 Apr 9;458(7239):757-61
19194461
Proteomics. 2009 Mar;9(5):1197-206
19253275
Biochem Cell Biol. 2006 Aug;84(4):528-35
16936825
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9047-52
18579779
Nat Struct Mol Biol. 2007 Nov;14(11):1008-16
17984963
Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):757-62
12524456
Mol Cell Biol. 2010 Jul;30(13):3216-32
20439497
Nat Rev Mol Cell Biol. 2010 Apr;11(4):264-75
20197778
Genome Res. 2009 Jun;19(6):967-77
19246569
FEBS J. 2005 Jan;272(1):141-51
15634339
Science. 2001 Feb 16;291(5507):1304-51
11181995
J Biol Chem. 2008 Sep 26;283(39):26771-81
18650421
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16686-91
19805358
Cell. 2006 Nov 3;127(3):635-48
17081983
Proc Natl Acad Sci U S A. 1984 Apr;81(7):1936-40
6326092
Epigenetics. 2010 Aug 16;5(6):460-8
20523115
Cell Metab. 2008 Sep;8(3):186-200
18762020
Cell. 2002 Nov 1;111(3):285-91
12419240
Biochem Cell Biol. 2005 Aug;83(4):468-76
16094450
Biochem Cell Biol. 2007 Aug;85(4):397-410
17713575
J Biol Chem. 2006 Jun 23;281(25):17180-17188
16613853
PLoS Genet. 2009 Oct;5(10):e1000687
19834540
Biochim Biophys Acta. 2009 Jun;1792(6):574-83
19327396
Cancer Res. 1994 Nov 1;54(21):5599-601
7923203
Biochem J. 2004 Oct 15;383(Pt 2):237-48
15242332
Mol Cell. 2002 Jun;9(6):1201-13
12086618
Gene. 1991 Jul 22;103(2):263-8
1889752
Mol Cell Proteomics. 2010 May;9(5):838-50
20150217
Nat Rev Mol Cell Biol. 2008 Mar;9(3):193-205
18200017
EMBO J. 2000 Jul 17;19(14):3714-26
10899125
Biochem Cell Biol. 2009 Feb;87(1):19-25
19234520
J Biol Chem. 2008 May 16;283(20):13611-26
18326493
J Biochem. 1982 Dec;92(6):1995-2000
7161271
Eur J Biochem. 1989 Jun 15;182(2):379-85
2661229
Mol Cell Proteomics. 2006 Mar;5(3):541-52
16319397
J Biol Chem. 2007 Mar 9;282(10):7641-55
17194708